Services Design Development Scientific Advice Project Management QA – Quality Assurance Monitoring Clinical Performance Data Management/eTrials Biostatistics Medical Writing Expert Statement Expertise Pharmacokinetics BA/BE Interactions Oncological trials Ophthalmological trials Inhalatives Transdermal Therapeutic Systems Children Sexual Hormones Therapeutic Expertise Clinical Development Phase I Phase II / Proof of Concept Phase III in OTC Phase III Non-Interventional Magnetic Marker Monitoring Medical Devices Nutrition Studies Clinical Pharmacology Unit Location Plan Capacity Technical Monitoring Ophthalmology Gynaecology Intensive Assessment Unit Clean Room Area Archive About Us Goals and Visions Our Experts Science Quality Library Presentations Library Publications Locations Career News EUFEPS Network on Dermatopharmacy just founded 22nd PKPD Expertentreffen in the heart of the Black Forest 3rd GBHI in Amsterdam: lively discussions and intensive exchange with authorities Meet us in Amsterdam: 3rd GBHI Conference starts soon (12 – 13 April 2018) Meet us in Munich: AGAH Annual Meeting 26 – 27 April 2018 Regorafenib: first in human as eye drops Probanden The SocraTec Family SocraTec C&S SocraMetrics Cooperations
Drug Food Interaction Consultancy Feasibility CDM Efficacy Referral system Female adolescents US FDA ANVISA CDSIC Database Copyright Auditing Standardisation Rhine Main area Design development Quality Dermal irritation Ophthalmological trials Metered dose inhaler Statistical programming WinNonlin Hypothalamic Phase IIa trials OTC Clinical pharmacology unit HTA US CFR 21 Part 11 DUS CDASH Centralised procedure Informed Consent Procedure Healthy subjects FIM PAES Patch adhesion MMM Monitoring Expert Pilot study NIS Endpoint Degeneration SDV Authorities Scientific expertise Edema Pituitary Legal representative HRT Recruitment rates Axis Good Clinical Practice Ophthalmologist DFI IB TTS Ophthalmology DDI Dry powder inhaler Transdermal therapeutic system Phase II Cough IVIVC Allergy IEC Xerostomia Asthma EMA Immunogenicity Thuringia GCP training COPD ADAM Clinical Monitoring Ovulation inhibition Safety Data Validation Plan ICF Inhalatives Creativity Protocol Central surveillance system CRO Absorption windows Steady state Bioequivalence Legal Information Children Clinical study Clinical trials Elpro Contraception Phase IIb trials Patients Post authorisation Dose linearity Phase I Unit Adrenocortical Drug Drug Interaction Phase III AGAH Sore throat Biopharmaceutical Protocol development Statistical Analysis Plan Spacious archive Quality Management System Pulse oximetry plethysmography Pragmatism Project Management Network Pharmacokintetics Data Management Plan Paediatricians Pharmacology FDA Investigators brochure Common cold PASS Oncologic network Phase I CRA DPI First in human Source Data Verification Oncology Patient recruitment Competence Pharmacodynamic studies GCP Macular Data management Charcoal CDISC Non interventional Intensive assessment station Hormone replacement therapy Lung SOP based SAS MCID IMPD Quality Assurance Subcontractor qualification Scientific advice Biometrics Sample size estimation Pharmacokinetics Audit CRF Standard operating procedure Inspection Clinical development program Slit lamp microscopy SocraTec C&S Phase IV Product development Eye disease Statistical services MDI Early phase Local tolerability HPA axis Highly variable drugs In vitro in vivo correlation Bioavailability Life cycle management Biosimilars Absorption GLP Sensitisation trials Sequential designs Cardiovascular surveillance Glaucoma Postmenopausal women Oncological patients Uveitis Patch Experience Gynaecological trials Biopharmaceutics Training Anaesthesiologist Dry eye Ocular tolerability  
 
Menu

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All fine on front page